Practice News

Beyfortus (nirsevimab) is an FDA approved and American Academy of Pediatrics (AAP) recommended injection that helps prevent serious lung disease caused by Respiratory Syncytial Virus (RSV) . This monoclonal antibody shot is available for all infants younger than 8 months of age during RSV season (typically October through the end of March). It is also available for some children 8 months to 19 months of age who are at increased risk for severe RSV disease and who are entering their second RSV season. Infants under 8 months of age whose mothers received the RSV vaccine (Abrysvo) during the 32nd-36th weeks of pregnancy should be protected for the season and will not need to get Beyfortus (as long as the vaccine was given 2 weeks before delivery). If you would like your child to get this recommended immunization, please contact your insurance company to ensure coverage, then call our office at 434-975-7777 to schedule an appointment. At this time, we can only offer Beyfortus at the Charlottesville (Rio Road) office, but will be offering it in the Crozet office soon.

The newest COVID-19 Moderna 2024-2025 season vaccine is now available in our offices for all children 6 months old through 11 years of age!

With measles on the rise globally, the Centers for Disease Control (CDC) is recommending that all international travelers get 2 doses of MMR (measles, mumps, rubella) vaccine at least 2 weeks before travel. Infants under 12 months old should get an early MMR dose at 6-11 months of age, with a second dose at 12-15 months, and a final dose at 4-6 years of age. Children over 12 months of age should get their first dose immediately, with a second dose 28+ days after the first dose. Teens and adults with no evidence of immunity (written documentation of adequate vaccination, laboratory evidence of immunity, or birth in the United States before 1957) should get their first dose immediately, with a second dose 28+ days after the first dose. Find more information on travel protection at this CDC link:

Here is an article about what pediatricians across the country have been seeing:

The American Academy of Pediatrics (AAP) just released a new policy and clinical report on PANS. Click here for more information here.

In September 2024, Consumer Reports tested for lead in ground cinnamon products and spice blends that contain cinnamon and found that 12 of 36 products measured above 1 part per million of lead—the threshold that triggers a recall in New York, the only state in the U.S. that regulates heavy metals in spices. The results from the CR study are linked in the NPR article (below) that also discusses the recall of applesauce pouches from October 2023: